Treatment strategies for non-small cell lung cancer (NSCLC) with EGFR mutations have evolved in recent years, including the development and approval of new therapies and combinations of treatments. The best treatment for each person with EGFR NSCLC depends on many factors, including the specific EGFR mutation, whether brain metastases are present, and the extent of the disease.

Dr. Shane Dormady from El Camino Hospital joined GO2’s October Lung Cancer Living Room® to discuss how new targeted therapies and a greater understanding of the disease have improved treatments for EGFR lung cancer. Early targeted therapy drugs performed better than traditional chemotherapy, but the cancer often developed resistance. Over the years, researchers developed 2nd- and 3rd-line drugs to combat these resistant mutations. Healthcare providers are also combining treatments (like immunotherapy and chemotherapy) and testing new drugs to improve outcomes for many people living with EGFR lung cancer.

Speakers:
  • Shane Dormady, MD, Hematology & Oncology, El Camino Hospital Cancer Center
  • Danielle Hicks, Chief Patient Officer, GO2 for Lung Cancer
Discussed in this episode:
  • Biomarker testing tells your healthcare team if the cancer has mutated or changed. These results guide your team in recommending the best treatment for you. Learn more about biomarker testing and why it’s important.
  • Clinical trials are an important consideration in your lung cancer treatment path. Understand this option more clearly by reviewing these frequently asked questions about clinical trials and reading our clinical trials brochure.
  • The U.S. Food and Drug Administration (FDA) has approved these drugs to treat EGFR lung cancer.
  • Read more information from ASCO 2024 about EGFR NSCLC.
  • Learn more about the difference between adjuvant and neo-adjuvant therapy.

Please join us on November 19 at 5:30 p.m. PT/8:30 p.m. ET for the next episode of the Lung Cancer Living Room, where we’ll discuss shared decision making and second opinions. Join in person at our San Carlos, CA office or watch on YouTube Live.

For more information on the Living Room, other GO2 for Lung Cancer programs, or support through diagnosis and treatment, please contact GO2’s HelpLine at 1-800-298-2436 or email support@go2.org.

You can now receive text reminders about upcoming Lung Cancer Living Room events by texting “LivingRoom” to 844-871-7558.